T-cell tumor necrosis factor-α receptor binding in myasthenic patients
暂无分享,去创建一个
[1] L. Murri,et al. T-cell interleukin-6 receptor binding in patients with myasthenia gravis , 1998, Journal of the Neurological Sciences.
[2] M. Castagna,et al. T-cell tumour necrosis factor-α receptor binding in demented patients , 1997, Journal of Neurology.
[3] H. Link,et al. Cytokines and the pathogenesis of myasthenia gravis , 1997, Muscle & nerve.
[4] P. Bongioanni,et al. T‐cell tumor necrosis factor‐α receptor binding in patients with multiple sclerosis , 1997, Neurology.
[5] A. Pinchera,et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. , 1997, The Journal of clinical endocrinology and metabolism.
[6] R. Pirskanen,et al. Tumor necrosis factor-α, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis , 1996, Journal of Neuroimmunology.
[7] R. Ransohoff,et al. Cytokines and the CNS , 1996 .
[8] N. Yanagisawa,et al. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy , 1994, Journal of Neuroimmunology.
[9] L. Tartaglia,et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. , 1993, Journal of immunology.
[10] R. Mantegazza,et al. Immune activation in myasthenia gravis: Soluble interleukin-2 receptor, interferon-γ and tumor necrosis factor-α levels in patients' serum , 1993, Journal of Neuroimmunology.
[11] O. Blin,et al. Pharmacological basis of immunotherapy in autoimmune diseases. , 1993, Clinical neuropharmacology.
[12] F. Sánchez‐Madrid,et al. Regulation of tumor necrosis factor (TNF)‐α synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway , 1992, European journal of immunology.
[13] C. Ware,et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. , 1991, Journal of immunology.
[14] S. Lowry,et al. Tumor necrosis factor-α , 1991 .
[15] T. Gatanaga,et al. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro. , 1991, Journal of immunology.
[16] R. Gentz,et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. , 1990, Cytokine.
[17] J. Newsom-Davis,et al. Autoimmunity in Neuromuscular Disease , 1988, Annals of the New York Academy of Sciences.
[18] J. Dipersio,et al. Tumor necrosis factor: receptors on hematopoietic cells. , 1987, Blood.
[19] P. Scheurich,et al. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. , 1987, Journal of immunology.
[20] R. Hohlfeld,et al. Myasthenia gravis , 1983, Neurology.
[21] Nicos Nicola,et al. Guidebook to cytokines and their receptors , 1994 .
[22] R. Smith,et al. Characterization of TNF receptors. , 1992, Immunology series.
[23] B. Aggarwal,et al. Tumor necrosis factors. Structure, function, and mechanism of action. , 1992, Immunology series.